| Nastassjia Giovanna Debourbon, MD | |
|
611 Alcorn Dr, Corinth, MS 38834-9388 | |
| (662) 293-1000 | |
| Not Available |
| Full Name | Nastassjia Giovanna Debourbon |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 611 Alcorn Dr, Corinth, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043943509 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | T-4594 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nastassjia Giovanna Debourbon, MD 611 Alcorn Dr, Corinth, MS 38834-9321 Ph: (662) 293-1000 | Nastassjia Giovanna Debourbon, MD 611 Alcorn Dr, Corinth, MS 38834-9388 Ph: (662) 293-1000 |
News Archive
Illicit drugs like marijuana, cocaine and heroin have always been a parent's nightmare. But perfectly legal and easily accessible prescription medications are now the recreational drugs of choice for many teenagers, prompting physicians at Johns Hopkins Children's Center to urge pediatricians to screen specifically for their abuse during routine visits.
Anti cancer drugs that have been rejected by the UK Government's new cancer drugs fund would still be available to needy patients according to the new ‘top-up' cash plan that is being launched. This Health Top-Up cash plan comes from Western Provident Association (WPA).
Synthes, Inc. (SWX: SYST.VX), a leading global medical device company in the orthopaedic trauma, spine, and cranio-maxillofacial markets, and Kensey Nash Corporation (Nasdaq: KNSY), a leading developer and manufacturer of innovative regenerative medicine products, today announced a strategic agreement for products developed from Kensey Nash's unique extracellular matrix (ECM) technology.
Protherics PLC today announced the initiation of a phase 2a proof-of-concept study of Prolarix, a targeted prodrug chemotherapy being developed for the treaent of primary liver cancer (hepatocellular carcinoma or "HCC"). This follows promising data from a phase 1 study of Prolarix, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA on 2 June 2008.
› Verified 7 days ago
Dr. Jessica Vo, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1000 | |
Amy B Davis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 Pratt Dr Ste 1a, Corinth, MS 38834 Phone: 662-286-0088 Fax: 662-286-0067 | |
Dr. John Andrew Cooper, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1000 | |
Bennett Davis, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 407-947-1369 | |
Dr. Kevin Jonathan Schwechten, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 Glenmore St, Corinth, MS 38834 Phone: 662-415-7732 | |
Dr. Porscha Cobb, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 611 Alcorn Dr, Corinth, MS 38834 Phone: 662-293-1000 |